Orbimed Advisors Llc - Significant Ownership

Signature - Title
/s/ Carl L. Gordon - Carl L. Gordon / Member
Location
New York, NY
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Orbimed Advisors Llc.

Significant Ownership of Orbimed Advisors Llc

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
TRAW Traws Pharma, Inc. Common Stock 19.9% $1.5M 761K ORBIMED ADVISORS LLC Dec 31, 2024
EWTX Edgewise Therapeutics, Inc. Common Stock 14.5% $174M 15.3M ORBIMED ADVISORS LLC May 9, 2025
ELVN Enliven Therapeutics, Inc. COMMON STOCK 13.4% $159M 7.92M ORBIMED ADVISORS LLC Jun 16, 2025
CRVS CORVUS PHARMACEUTICALS, INC. Common stock, par value $0.0001 per share (the "Shares"). 12.2% $28.5M 9.79M 0% ORBIMED ADVISORS LLC May 12, 2025
STTK Shattuck Labs, Inc. Common Stock, par value $0.0001 per share 9.99% $6.31M 6.31M ORBIMED ADVISORS LLC Aug 25, 2025
ACET Adicet Bio, Inc. Common Stock, par value $0.0001 9.6% $12M 14.8M ORBIMED ADVISORS LLC Oct 8, 2025
PMVP PMV Pharmaceuticals, Inc. COMMON STOCK 9.4% $6.97M 4.98M ORBIMED ADVISORS LLC Oct 23, 2025
MBX MBX Biosciences, Inc. COMMON STOCK 9% $55.6M 4M ORBIMED ADVISORS LLC Sep 26, 2025
CMPX Compass Therapeutics, Inc. COMMON STOCK 8.9% $49.9M 15.2M 0% ORBIMED ADVISORS LLC Aug 13, 2025
AVTX Avalo Therapeutics, Inc. Common Stock, par value $0.001 per share 8.9% $9.55M 967K OrbiMed Advisors LLC Jun 30, 2025
WHWK Whitehawk Therapeutics, Inc. Common Stock, par value $0.0001 per share 8.9% $6.87M 4.17M OrbiMed Advisors LLC Mar 31, 2025
SION Sionna Therapeutics, Inc. Common Stock 8.4% $28.4M 3.7M ORBIMED ADVISORS LLC Feb 10, 2025
NPCE NeuroPace Inc Common Stock, par value $0.001 per share 8% $23.8M -$7.22M 2.61M -23.3% OrbiMed Advisors LLC Jun 30, 2025
FBRX Forte Biosciences, Inc. Common Stock, par value $0.001 per share 8% $2.72M 510K ORBIMED ADVISORS LLC Dec 31, 2024
AVBP ArriVent BioPharma, Inc. Common Stock 7.5% $58.2M 3.03M ORBIMED ADVISORS LLC Aug 11, 2025
IKNA ImageneBio, Inc. COMMON STOCK 6.92% $820K -$7.67M 774K -90.3% ORBIMED ADVISORS LLC Jul 25, 2025
RAPT RAPT Therapeutics, Inc. Common Stock, par value $0.0001 per share 6.6% $28M -$311M 1.09M -91.7% ORBIMED ADVISORS LLC Sep 30, 2025
CRBP Corbus Pharmaceuticals Holdings, Inc. Common Stock, par value $0.0001 per share 5.9% $3.61M 718K OrbiMed Capital LLC Dec 31, 2024
CTMX CytomX Therapeutics, Inc. Common Stock, par value $0.00001 per share 5.4% $16.9M 8.46M OrbiMed Advisors LLC Jun 30, 2025
VTGN Vistagen Therapeutics, Inc. Common Stock, par value $0.001 per share 5.34% $5.73M 1.64M ORBIMED CAPITAL LLC Sep 30, 2025
CCCC C4 Therapeutics, Inc. Common Stock, par value $0.0001 per share 5% $7.92M -$2.41M 3.57M -23.4% OrbiMed Capital LLC Sep 30, 2025
TERN Terns Pharmaceuticals, Inc. Common Stock 4.8% $31.8M 4.24M ORBIMED ADVISORS LLC Nov 3, 2025
IRON Disc Medicine, Inc. Common Stock 4.5% $60.3M 1.56M ORBIMED ADVISORS LLC Mar 10, 2025
PASG Passage BIO, Inc. COMMON STOCK 4.25% $43.7K -$36.8K 132K -45.7% ORBIMED ADVISORS LLC Jul 22, 2025
NSPR InspireMD, Inc. Common Stock, par value $0.0001 per share 4.1% $5.14M 2.13M 0% OrbiMed Advisors LLC Sep 30, 2025
ADCT ADC Therapeutics SA Common Shares, par value CHF 0.08 per share 3.6% $4.19M 3.44M ORBIMED CAPITAL LLC Dec 31, 2024
VSTM Verastem, Inc. Common Stock, par value $0.0001 per share 2.4% $12.1M -$13.9M 1.33M -53.4% ORBIMED ADVISORS LLC Jun 30, 2025
XFOR X4 Pharmaceuticals, Inc Common Stock, par value $0.001 per share 1.7% $25.6K 135K ORBIMED ADVISORS LLC Jun 30, 2025
XTNT Xtant Medical Holdings, Inc. COMMON STOCK 0% $0 0 ORBIMED ADVISORS LLC Apr 10, 2025

Schedules 13D/G Reported by Orbimed Advisors Llc:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.